Olin Corporation (OLN) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.32%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value -0.58×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.32% | Share-based compensation / revenue. Period ending 2026-06-30. $21.30M ÷ $6.70B × 100 ≈ 0.32% |
| Interest coverage · 12 months | -0.58× | Operating income ÷ reported interest expense. $-105.50M ÷ $181.80M ≈ -0.58× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 6.70B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 21.30M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -105.50M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 181.80M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $6.70B | $21.30M | $-105.50M | $181.80M | (m) | 0.32% | -0.58× | Reported |
| 2026-03-31 | (m) | $6.72B | $21.40M | $-116.70M | $183.00M | (m) | 0.32% | -0.64× | Reported |
| 2025-12-31 | (m) | $6.78B | $20.70M | $5.30M | $188.30M | (m) | 0.31% | 0.03× | Reported |
| 2025-09-30 | (m) | $6.79B | $20.90M | $209.10M | $187.00M | (m) | 0.31% | 1.12× | Reported |
| 2025-06-30 | (m) | $6.66B | $20.90M | $141.80M | $188.60M | (m) | 0.31% | 0.75× | Reported |
| 2025-03-31 | (m) | $6.55B | $16.70M | $242.90M | $188.40M | (m) | 0.26% | 1.29× | Reported |
| 2024-12-31 | (m) | $6.54B | $17.10M | $296.50M | $184.50M | (m) | 0.26% | 1.61× | Reported |
| 2024-09-30 | (m) | $6.48B | $17.20M | $348.20M | $186.80M | (m) | 0.27% | 1.86× | Reported |
| 2024-06-30 | (m) | $6.57B | $16.60M | $498.70M | $184.60M | (m) | 0.25% | 2.70× | Reported |
| 2024-03-31 | (m) | $6.62B | $19.30M | $579.00M | $183.30M | (m) | 0.29% | 3.16× | Reported |
| 2023-12-31 | (m) | $6.83B | $18.60M | $712.10M | $181.10M | (m) | 0.27% | 3.93× | Reported |
| 2023-09-30 | (m) | $7.20B | $16.90M | $886.70M | $174.40M | (m) | 0.23% | 5.08× | Reported |
| 2023-06-30 | (m) | $7.85B | $16.20M | $1.11B | $164.20M | (m) | 0.21% | 6.79× | Reported |
| 2023-03-31 | (m) | $8.76B | $14.70M | $1.46B | $153.40M | (m) | 0.17% | 9.54× | Reported |
| 2022-12-31 | (m) | $9.38B | $14.10M | $1.78B | $143.90M | (m) | 0.15% | 12.36× | Reported |
| 2022-09-30 | (m) | $9.83B | $13.70M | $2.03B | $247.00M | (m) | 0.14% | 8.22× | Reported |
| 2022-06-30 | (m) | $9.85B | $13.30M | $2.19B | $265.00M | (m) | 0.14% | 8.25× | Reported |
| 2022-03-31 | (m) | $9.45B | $9.40M | $2.02B | $296.40M | (m) | 0.10% | 6.80× | Reported |
| 2021-12-31 | (m) | $8.91B | $8.30M | $1.85B | $348.00M | (m) | 0.09% | 5.32× | Reported |
| 2021-09-30 | (m) | $8.13B | $11.50M | $1.41B | $290.00M | (m) | 0.14% | 4.85× | Reported |
| 2021-06-30 | (m) | $7.23B | $10.80M | $172.80M | $310.60M | (m) | 0.15% | 0.56× | Reported |
| 2021-03-31 | (m) | $6.25B | $15.40M | $-318.00M | $314.10M | (m) | 0.25% | -1.01× | Reported |
| 2020-12-31 | (m) | $5.76B | $13.60M | $-746.70M | $292.70M | (m) | 0.24% | -2.55× | Reported |
| 2020-09-30 | (m) | $5.49B | $8.90M | $-876.40M | $271.10M | (m) | 0.16% | -3.23× | Reported |
| 2020-06-30 | (m) | $5.63B | $9.50M | $-89.20M | $260.40M | (m) | 0.17% | -0.34× | Reported |
| 2020-03-31 | (m) | $5.98B | $7.60M | $35.10M | $248.90M | (m) | 0.13% | 0.14× | Reported |
| 2019-12-31 | (m) | $6.11B | $10.70M | $177.80M | $243.20M | (m) | 0.18% | 0.73× | Reported |
| 2019-09-30 | (m) | $6.36B | $11.70M | $353.90M | $238.40M | (m) | 0.18% | 1.48× | Reported |
| 2019-06-30 | (m) | $6.65B | $11.10M | $565.00M | $233.70M | (m) | 0.17% | 2.42× | Reported |
| 2019-03-31 | (m) | $6.79B | $12.20M | $687.20M | $236.90M | (m) | 0.18% | 2.90× | Reported |
| 2018-12-31 | (m) | $6.95B | $12.00M | $676.90M | $243.20M | (m) | 0.17% | 2.78× | Reported |
| 2018-09-30 | (m) | $6.93B | $11.90M | $694.60M | $243.40M | (m) | 0.17% | 2.85× | Reported |
| 2018-06-30 | (m) | $6.61B | $11.30M | $484.30M | $237.30M | (m) | 0.17% | 2.04× | Reported |
| 2018-03-31 | (m) | $6.41B | $10.70M | $354.80M | $228.70M | (m) | 0.17% | 1.55× | Reported |
| 2017-12-31 | (m) | $6.27B | $9.10M | $331.00M | $217.40M | (m) | 0.15% | 1.52× | Reported |
| 2017-09-30 | (m) | $6.03B | $7.80M | $281.10M | $206.30M | (m) | 0.13% | 1.36× | Reported |
| 2017-06-30 | (m) | $5.93B | $7.80M | $236.30M | $200.70M | (m) | 0.13% | 1.18× | Reported |
| 2017-03-31 | (m) | $5.77B | $6.80M | $229.60M | $195.80M | (m) | 0.12% | 1.17× | Reported |
| 2016-12-31 | (m) | $5.55B | $7.50M | $152.60M | $191.90M | (m) | 0.14% | 0.80× | Reported |
| 2016-09-30 | (m) | $5.43B | $8.20M | $54.10M | $200.90M | (m) | 0.15% | 0.27× | Reported |
| 2016-06-30 | (m) | $4.51B | $7.60M | $9.20M | $167.80M | (m) | 0.17% | 0.05× | Reported |
| 2016-03-31 | (m) | $3.68B | $8.00M | $67.30M | $138.40M | (m) | 0.22% | 0.49× | Reported |
| 2015-12-31 | (m) | $2.85B | $7.60M | $100.70M | $97.00M | (m) | 0.27% | 1.04× | Reported |
| 2015-09-30 | (m) | $2.09B | $7.10M | $155.50M | $46.50M | (m) | 0.34% | 3.34× | Reported |
| 2015-06-30 | (m) | $2.15B | $6.40M | $189.90M | $49.80M | (m) | 0.30% | 3.81× | Reported |
| 2015-03-31 | (m) | $2.18B | $4.80M | $172.20M | $41.20M | (m) | 0.22% | 4.18× | Reported |
| 2014-12-31 | (m) | $2.24B | $5.10M | $203.40M | $43.80M | (m) | 0.23% | 4.64× | Reported |
| 2014-09-30 | (m) | $2.30B | $5.90M | $212.60M | $46.90M | (m) | 0.26% | 4.53× | Reported |
| 2014-06-30 | (m) | $2.38B | $7.10M | $259.00M | $39.10M | (m) | 0.30% | 6.62× | Reported |
| 2014-03-31 | (m) | $2.46B | $8.80M | $269.30M | $39.20M | (m) | 0.36% | 6.87× | Reported |
| 2013-12-31 | (m) | $2.52B | $8.80M | $286.50M | $38.60M | (m) | 0.35% | 7.42× | Reported |
| 2013-09-30 | (m) | $2.54B | $8.40M | $317.70M | $36.80M | (m) | 0.33% | 8.63× | Reported |
| 2013-06-30 | (m) | $2.45B | $7.80M | $267.50M | $32.90M | (m) | 0.32% | 8.13× | Reported |
| 2013-03-31 | (m) | $2.31B | $6.90M | $264.10M | $29.00M | (m) | 0.30% | 9.11× | Reported |
| 2012-12-31 | (m) | $2.18B | $6.20M | $258.90M | $26.40M | (m) | 0.28% | 9.81× | Reported |
| 2012-09-30 | (m) | $2.04B | $5.70M | $229.70M | $26.20M | (m) | 0.28% | 8.77× | Reported |
| 2012-06-30 | (m) | $2.01B | $5.40M | $254.10M | $28.10M | (m) | 0.27% | 9.04× | Reported |
| 2012-03-31 | (m) | $2.03B | $5.80M | $254.50M | $29.70M | (m) | 0.29% | 8.57× | Reported |
| 2011-12-31 | (m) | $1.96B | $5.80M | $223.90M | $30.40M | (m) | 0.30% | 7.37× | Reported |
| 2011-09-30 | (m) | $1.90B | $5.90M | $182.00M | $28.40M | (m) | 0.31% | 6.41× | Reported |
| 2011-06-30 | (m) | $1.78B | $6.10M | $137.40M | $26.90M | (m) | 0.34% | 5.11× | Reported |
| 2011-03-31 | (m) | $1.66B | $6.60M | $88.80M | $25.70M | (m) | 0.40% | 3.46× | Reported |
| 2010-12-31 | (m) | $1.59B | $6.70M | $69.90M | $25.40M | (m) | 0.42% | 2.75× | Reported |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | $1.53B | $5.80M | $182.60M | $11.60M | (m) | 0.38% | 15.74× | Reported |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | $1.76B | $6.30M | $251.20M | $13.30M | (m) | 0.36% | 18.89× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Chemours Co (CC) | United States | $2.136B | -10.64 |
| Huntsman CORP (HUN) | United States | $1.540B | -6.95 |
| INNOSPEC INC. (IOSP) | United States | $2.380B | 16.37 |
| Ingevity Corp (NGVT) | United States | $2.468B | 47.72 |
| FMC CORP (FMC) | United States | $1.201B | -0.52 |
| Ecovyst Inc. (ECVT) | United States | $1.110B | -22.22 |
| ASCENT INDUSTRIES CO. (ACNT) | United States | $0.132B | -30.55 |
| CitroTech Inc. (CITR) | United States | $0.097B | -5.12 |
| Loop Industries, Inc. (LOOP) | $0.023B | -5.50 | |
| GULF RESOURCES, INC. (GURE) | $0.006B |